Methyl-Substituted Conformationally Constrained Rexinoid Agonists for the Retinoid X Receptors Demonstrate Improved Efficacy for Cancer Therapy and Prevention
Bioorganic and Medicinal Chemistry - United Kingdom
doi 10.1016/j.bmc.2013.11.039
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2014
Authors
Publisher
Elsevier BV